However, even in this large nationally representative claims database, there were only 1 160 users of both acetylcholinesterase inhibitors and anticholinergics for overactive bladder in the Duals population compared to 15 639 users among Medicare enrollees. This evidence concerns the gene ACHE and overactive bladder.